Work

Lb-05phase Iii Trial Exploring the Combination of Bevacizumab and Lomustine in Patients With First Recurrence of a Glioblastoma: the Eortc 26101 Trial

Year: 2015

Type: article

Study designs: Randomized Controlled Trial, Clinical Trial

Source: Neuro-Oncology

DOI: 10.1093/neuonc/nov306

Authors: W. Wick, AA. Brandes, T. Gorlia, M. Bendszus, F. Sahm, W. Taal, M. Taphoorn, J. Domont, A. Idbaih, M. Campone, P.M. Clement, R. Stupp, M. Fabbro, F. Dubois, C. Bais, D. Musmeci, M. Platten, M. Weller, V. Golfinopoulos, M. van den Bent

Institutions: German Cancer Research Center, Istituto delle Scienze Neurologiche di Bologna, European Organisation for Research and Treatment of Cancer, Daniel den Hoed Kliniek, Medisch Centrum Haaglanden, Stichting Haaglanden Medisch Centrum, Institut Gustave Roussy, Assistance Publique – Hôpitaux de Paris, Pitié-Salpêtrière Hospital, Université Pierre-et-Marie-Curie, Institut de Cancérologie de l'Ouest, KU Leuven, University Hospital Zurich, Institut Regional du Cancer de Montpellier, Centre Hospitalier Universitaire de Lille, Genentech

Language: English

Topic: Glioma Diagnosis and Treatment

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2275199929

FWCI: 10.64

Cites:

Cited by: 80

Related to: 10